Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Resche-Rigon

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
Journal of Neuroendocrinology|June 22, 2023
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECISTLouis de Mestier, Matthieu Resche-Rigon, Clarisse Dromain, et al.
Journal of Neurointerventional Surgery|August 27, 2025
Glenzocimab for reperfusion in the setting of endovascular therapy for brain infarction: GREEN studyMikaël Mazighi, Jerome Lambert, Benjamin Gory, et al.
American Journal of Ophthalmology|February 5, 2026
Adalimumab, Anakinra and Tocilizumab in patients with non-infectious Uveitis: A multicenter randomized controlled trialDavid Saadoun, Amine Ghembaza, Sarah Touhami, et al.
Eclinicalmedicine|July 15, 2024
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort studyAlizée Bozonnat, Marie Beylot-Barry, Olivier Dereure, et al.
Eclinicalmedicine|December 25, 2024
Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort studyAlizée Bozonnat, Marie Beylot-Barry, Olivier Dereure, et al.
JCI Insight|January 23, 2026
Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of deathOlivia Lenoir, Florence Morin, Anouk Walter-Petrich, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
International Journal of Bipolar Disorders|September 26, 2019
Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiativeJan Scott, Diego Hidalgo-Mazzei, Rebecca Strawbridge, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Journal of Neuroendocrinology|June 22, 2023
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECISTLouis de Mestier, Matthieu Resche-Rigon, Clarisse Dromain, et al.
Journal of Neurointerventional Surgery|August 27, 2025
Glenzocimab for reperfusion in the setting of endovascular therapy for brain infarction: GREEN studyMikaël Mazighi, Jerome Lambert, Benjamin Gory, et al.
American Journal of Ophthalmology|February 5, 2026
Adalimumab, Anakinra and Tocilizumab in patients with non-infectious Uveitis: A multicenter randomized controlled trialDavid Saadoun, Amine Ghembaza, Sarah Touhami, et al.
Eclinicalmedicine|July 15, 2024
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort studyAlizée Bozonnat, Marie Beylot-Barry, Olivier Dereure, et al.
Eclinicalmedicine|December 25, 2024
Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort studyAlizée Bozonnat, Marie Beylot-Barry, Olivier Dereure, et al.
JCI Insight|January 23, 2026
Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of deathOlivia Lenoir, Florence Morin, Anouk Walter-Petrich, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
International Journal of Bipolar Disorders|September 26, 2019
Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiativeJan Scott, Diego Hidalgo-Mazzei, Rebecca Strawbridge, et al.
Pageof 20